ClinicalTrials.Veeva

Menu

Prevalence of Primary Aldosteronism in Atrial Fibrillation (ERETRIA)

A

Aristotle University Of Thessaloniki

Status

Enrolling

Conditions

Atrial Fibrillation
Primary Aldosteronism

Treatments

Diagnostic Test: Screening and Confirmatory diagnostic test for primary aldosteronism

Study type

Observational

Funder types

Other

Identifiers

NCT05973604
4418/26/01/2021

Details and patient eligibility

About

This is an observational prospective cross-sectional study, investigating the prevalence of primary aldosteronism in patients with atrial fibrillation.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Established diagnosis of atrial fibrillation with a standard surface ECG tracing of at least 30 seconds (either paroxysmal or persistent or permanent).

Exclusion criteria

  • Diagnosis of primary aldosteronism
  • Diagnosis of heart failure, treated with mineralocorticoid receptor antagonists
  • Inability to be subjected to any confirmatory tests for primary aldosteronism
  • Acute vascular event (acute coronary syndrome, stroke, acute peripheral vascular event) within last 6 months
  • Renal replacement therapy
  • Incompetence of unwillingness to provide written informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Vassilios P Vassilikos, PhD; Maria Toumpourleka, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems